期刊文献+

福建汉族人群人类血小板抗原HPA-15多态性分析(附113例报告) 被引量:3

Human platelet antigen-15 polymorphism in Fujian Han populations
下载PDF
导出
摘要 目的分析福建汉族人群人类血小板抗原(HPA)-15基因多态性,为临床血小板输注提供依据。方法采用聚合酶链反应-序列特异引物法(PCR-SSP)技术对113名福建汉族健康个体进行HPA-15基因分型。结果HPA-15aa、HPA-15ab及HPA-15bb的分布频率分别为0.274、0.522和10.204,与我国其他省份汉族人群比较,差异无统计学意义。HPA-15a、HPA-15b抗原不配合率分别为0.116和10.133。结论HPA-15基因多态性区域差异不明显。HPA-15a/b抗原不配合率较HPA其他系统高,可能导致产生同种免疫性血小板抗体的概率增加,在临床血小板输注中的作用值得重视。 Objective To investigate the polymorphism of human platelet antigen-15 (HPA-15) in Fujian Han population and to provide valuable data for clinical platelet transfusion. Methods HPA-15 system genotype was determined by PCR-SSP method in 113 healthy individuals from Fujian province. Results The frequencies of HPA-15aa, HPA-15ab and HPA-15bb in Fujian Han population were 0. 274, 0. 522 and 0. 204, respectively. Compared with some, Han populations in china, there was not significantly difference. The frequencies of antigen incompatibility of HPA-15a and HPA-15b were 0. 116 and 0. 133, respectively. Conclusion No significantly difference is observed in the frequency distribution of HPA-15 between Fujian Han population and other provincial Han populations. The frequencies of antigen incompatibility of HPA-15a and HPA-15b are highler than other HPA systems, which indicate HPA-15 may increase the probability of human platelet alloimmunization and may play an important role in clinical platelet transfusion.
机构地区 福建省肿瘤医院
出处 《福建医药杂志》 CAS 2007年第5期123-125,共3页 Fujian Medical Journal
关键词 血小板抗原 基因频率 Human platelet antigen Gene frequency
  • 相关文献

参考文献6

二级参考文献26

  • 1孙国栋,段现民,张彦平,尹志柱,牛小利,李艳凤,牛海江,赵有良.献血者血小板1-16抗原基因遗传多态性分析及已知HPA型供者数据库的建立[J].中国实验血液学杂志,2005,13(5):889-895. 被引量:39
  • 2Metcalfe P,Watkins NA,Ouwehand WH,et al.Nomenclature of human platelet antigens[J].Vox Sang,2003,85(3):240
  • 3Kelton JG,Smith JW,Horsewood P,et al.Gova/b alloantigen system on human platelets[J].Blood,1990,75(11):2172
  • 4Schuh,AC,Watkins,NA,Nguyen,Q,et al,A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens[J].Blood,2002(99):1692
  • 5Cardone JDB,Chiba AK,et al.Gene frequencies of the HPA-15 (Gov) platelet alloantigen system in Brazilians[J].Transfusion Med,2004,14:433
  • 6European Bioimformatic Institute.Available at http://www.ebi.ac.uk/ipd/hpa/2006-4-13
  • 7Kekomaki S,Volin L,Koistinen P,et al.Successful treatment of platelet transfusion refractoriness:the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemia[J].Eur J Haematol,1998,60(2):112
  • 8Kekomaki R.Use of HLA-and HPA-matched platelets in alloimmunized patients[J].Vox Sang,1998,74(Suppl 2):359
  • 9Loren AW,Abrams CS.Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura.Am J Hematol,2004,76(3):258
  • 10Pappalardo PA,Secord AR,Quitevis P,et al.Platelet transfusion refractoriness associated with HPA-1a[Pl(A1)] alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.Transfusion,2001,41(8):984

共引文献42

同被引文献50

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部